EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model

Ilkay Irem Ozbek iD, Kutlu O Ulgen iD

Molecules · 12.01.2023 · 28 (2) · 779

DOI: 10.3390/molecules28020779 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 12.01.2023. Verfasst von Ilkay Irem Ozbek und 1 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Engineering Department, Bogazici University, Bebek, Istanbul 34342, Turkey. Hauptthemen laut MEDLINE: Medulloblastoma, Brain Neoplasms, Cerebellar Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tekfen Holding, Scientific Research Projects (BAP) Coordination Unit and the TEKFEN Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medulloblastoma (MB), occurring in the cerebellum, is the most common childhood brain tumor. Because conventional methods decline life quality and endanger children with detrimental side effects, computer models are needed to imitate the characteristics of cancer cells and uncover effective therapeutic targets with minimum toxic effects on healthy cells. In this study, metabolic changes specific to MB were captured by the genome-scale metabolic brain model integrated with transcriptome data. To determine the roles of sphingolipid metabolism in proliferation and metastasis in the cancer cell, 79 reactions were incorporated into the MB model. The pathways employed by MB without a carbon source and the link between metastasis and the Warburg effect were examined in detail. To reveal therapeutic targets for MB, biomass-coupled reactions, the essential genes/gene products, and the antimetabolites, which might deplete the use of metabolites in cells by triggering competitive inhibition, were determined. As a result, interfering with the enzymes associated with fatty acid synthesis (FAs) and the mevalonate pathway in cholesterol synthesis, suppressing cardiolipin production, and tumor-supporting sphingolipid metabolites might be effective therapeutic approaches for MB. Moreover, decreasing the activity of succinate synthesis and GABA-catalyzing enzymes concurrently might be a promising strategy for metastatic MB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MedulloblastomaBrain NeoplasmsCerebellar NeoplasmsChildHumansCerebellumTranscriptomeCell Line, Tumor

Stichwörter der Autor:innen

drug targetmedulloblastomametabolic brain modelsphingolipid metabolismsystems biology

Autor:innen und Institutionen

  • Chemical Engineering Department, Bogazici University, Bebek, Istanbul 34342, Turkey.

ORCID-Profile: Ilkay Irem Ozbek, Kutlu O Ulgen

Förderung

  • Tekfen Holding
  • Scientific Research Projects (BAP) Coordination Unit and the TEKFEN Foundation

Zitieren

APA

Ozbek, I. I., & Ulgen, K. O. (2023). Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules, 28(2), 779. https://doi.org/10.3390/molecules28020779

Vancouver

Ozbek II, Ulgen KO. Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model. Molecules. 2023;28(2):779. doi:10.3390/molecules28020779

BibTeX
@article{Ozbek2023,
  author = {Ozbek, Ilkay Irem and Ulgen, Kutlu O},
  title = {Identification of Therapeutic Targets for Medulloblastoma by Tissue-Specific Genome-Scale Metabolic Model},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {2},
  pages = {779},
  doi = {10.3390/molecules28020779}
}
Kostenlos starten →